Cereno Scientific AB (CRNO_B) Posts Positive CS014 PK-Bridging, Plans Direct Path to Phase IIb

Cereno Scientific reported positive topline Phase I PK-bridging results for CS014 versus VPA, supporting its plan to advance directly to a Phase IIb trial in PH-ILD, subject to FDA review. IND submission is planned for Q4 2026 with Phase IIb expected to start in Q3 2027.Material DetailsContext by A…